O.P. Purohit

1.2k total citations
30 papers, 942 citations indexed

About

O.P. Purohit is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, O.P. Purohit has authored 30 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in O.P. Purohit's work include Bone health and treatments (23 papers), Cancer Diagnosis and Treatment (13 papers) and Medical Imaging and Pathology Studies (9 papers). O.P. Purohit is often cited by papers focused on Bone health and treatments (23 papers), Cancer Diagnosis and Treatment (13 papers) and Medical Imaging and Pathology Studies (9 papers). O.P. Purohit collaborates with scholars based in United Kingdom, Belgium and Switzerland. O.P. Purohit's co-authors include Robert E. Coleman, J. Vinholes, Sandra A. Gutcher, Janet E. Brown, Richard Eastell, RE Coleman, Mavis Abbey, Jamal Zekri, Sue Ellis and C S Thomson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

O.P. Purohit

30 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O.P. Purohit United Kingdom	14	831	379	274	238	180	30	942
T. Taube Finland	12	515 0.6×	201 0.5×	162 0.6×	119 0.5×	87 0.5×	15	620
Bijvoet Ol Netherlands	10	515 0.6×	128 0.3×	150 0.5×	266 1.1×	50 0.3×	17	720
H. Kässmann Austria	9	292 0.4×	110 0.3×	70 0.3×	151 0.6×	161 0.9×	20	669
Andrea Keck Austria	9	293 0.4×	74 0.2×	102 0.4×	152 0.6×	36 0.2×	16	484
Roberto Santos Brazil	12	257 0.3×	111 0.3×	80 0.3×	35 0.1×	86 0.5×	23	594
Rebecca Pedersini Italy	15	306 0.4×	32 0.1×	180 0.7×	95 0.4×	95 0.5×	41	551
Timo Kylmälä Finland	11	343 0.4×	163 0.4×	277 1.0×	58 0.2×	112 0.6×	18	514
Kazuhiro Majima Japan	12	100 0.1×	119 0.3×	151 0.6×	88 0.4×	303 1.7×	20	724
Mauro Mari Italy	8	217 0.3×	75 0.2×	345 1.3×	95 0.4×	42 0.2×	10	469
R. Pellerito Italy	13	94 0.1×	86 0.2×	45 0.2×	106 0.4×	173 1.0×	31	556

Countries citing papers authored by O.P. Purohit

Since Specialization

Citations

This map shows the geographic impact of O.P. Purohit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.P. Purohit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.P. Purohit more than expected).

Fields of papers citing papers by O.P. Purohit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.P. Purohit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.P. Purohit. The network helps show where O.P. Purohit may publish in the future.

Co-authorship network of co-authors of O.P. Purohit

This figure shows the co-authorship network connecting the top 25 collaborators of O.P. Purohit. A scholar is included among the top collaborators of O.P. Purohit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.P. Purohit. O.P. Purohit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Purohit, O.P., et al.. (2024). Methadone in Cancer-Related Neuropathic Pain: A Narrative Review. Current Oncology. 31(12). 7613–7624. 1 indexed citations

Lester, J., David Dodwell, Janet E. Brown, et al.. (2012). Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial. Journal of bone oncology. 1(2). 57–62. 15 indexed citations

Hatton, M., et al.. (2010). Review of Testing and Use of Adjuvant Trastuzumab across a Cancer Network — Are We Treating the Right Patients?. Clinical Oncology. 22(4). 289–293. 13 indexed citations

Murray, Louise, et al.. (2010). Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery. The Breast. 19(5). 339–344. 14 indexed citations

Brown, Janet E., R.A. Hannon, Sue Ellis, et al.. (2009). The use of a point of care device for monitoring the bone resorption biomarker urinary N-telopeptide in cancer patients with bone metastases. Bone. 46(3). 801–805. 3 indexed citations

Zekri, Jamal, et al.. (2008). Epirubicin/Vinorelbine Adjuvant Chemotherapy in Young Women with Breast Cancer is Associated with Preservation of Menstrual Function. Clinical Oncology. 20(7). 513–516. 7 indexed citations

Lester, J., David Dodwell, O.P. Purohit, et al.. (2008). Use of monthly oral ibandronate to prevent anastrozole-induced bone loss during adjuvant treatment for breast cancer: Two-year results from the ARIBON study. Journal of Clinical Oncology. 26(15_suppl). 554–554. 13 indexed citations

Brown, J. E., Eugène McCloskey, J Dewar, et al.. (2007). The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease. Calcified Tissue International. 81(5). 341–351. 20 indexed citations

Lester, J., Sandra A. Gutcher, Sue Ellis, et al.. (2007). Effect of monthly oral ibandronate on anastrozole-induced bone loss during adjuvant treatment for breast cancer: One-year results from the ARIBON study. Journal of Clinical Oncology. 25(18_suppl). 553–553. 11 indexed citations

10.

Brown, Janet E., Eugène McCloskey, J Dewar, et al.. (2004). A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption. Journal of Clinical Oncology. 22(14_suppl). 8056–8056. 1 indexed citations

11.

Brown, Janet E., C S Thomson, Sue Ellis, et al.. (2003). Bone resorption predicts for skeletal complications in metastatic bone disease. British Journal of Cancer. 89(11). 2031–2037. 129 indexed citations

12.

Jagdev, S., et al.. (2001). Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease. Annals of Oncology. 12(10). 1433–1438. 79 indexed citations

13.

Coleman, Robert E., et al.. (1999). Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease. Annals of Oncology. 10(3). 311–316. 80 indexed citations

14.

Coleman, Robert E., Stephen Houston, O.P. Purohit, et al.. (1998). A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. European Journal of Cancer. 34(6). 820–824. 33 indexed citations

15.

Vinholes, J., Chun Guo, O.P. Purohit, Richard Eastell, & RE Coleman. (1997). Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.. Journal of Clinical Oncology. 15(1). 131–138. 58 indexed citations

16.

Vinholes, J., O.P. Purohit, Mavis Abbey, Richard Eastell, & Robert E. Coleman. (1997). Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease. Annals of Oncology. 8(12). 1243–1250. 136 indexed citations

17.

Coleman, RE, O.P. Purohit, J. Vinholes, & Jamal Zekri. (1997). High dose pamidronate. Cancer. 80(S8). 1686–1690. 50 indexed citations

18.

Coleman, Robert E., O.P. Purohit, & J. Vinholes. (1996). The Future of Bisphosphonates in Cancer. Acta Oncologica. 35(sup5). 23–29. 1 indexed citations

19.

Coleman, Robert E. & O.P. Purohit. (1993). Osteoclast inhibition for the treatment of bone metastases. Cancer Treatment Reviews. 19(1). 79–103. 36 indexed citations

20.

Purohit, O.P., et al.. (1977). The peripheral eosinophil counts as a monitor during radiotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(1). 97–100. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact